Overall, these data demonstrate that Ad vectors combine fast and efficient reprogramming with tumor transduction capacity in situ, providing a delivery platform for a cancer gene therapy approach based on cDC1 reprogramming. This evidence concerns the gene MPPE1 and neoplasm.